abstract |
combination of regorafenib and acetylsalicylic acid for the treatment of cancer. The present invention relates to pharmaceutical compositions and combinations comprising regorafenib and acetylsalicylic acid, or a hydrate, solvate, metabolite or pharmaceutically acceptable salt thereof, or a polymorph thereof, for the treatment, prevention or management of diseases and conditions, including hyperproliferative disorders such as as cancer in humans and other mammals. |